| 1 |
33402502 | ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy. | 2021 Jan-Feb |
3 |
| 2 |
33791146 | IAP-1 promoted cisplatin resistance in nasopharyngeal carcinoma via inhibition of caspase-3-mediated apoptosis. | 2021 |
1 |
| 3 |
33827148 | Role of FOXO protein's abnormal activation through PI3K/AKT pathway in platinum resistance of ovarian cancer. | 2021 Jun |
1 |
| 4 |
33904759 | Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination. | 2021 Sep |
1 |
| 5 |
34068084 | The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice. | 2021 May 13 |
1 |
| 6 |
34337539 | Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal Disease. | 2021 Jul |
1 |
| 7 |
34948122 | New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors. | 2021 Dec 11 |
1 |
| 8 |
32275806 | Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial Cancer. | 2020 Aug |
2 |
| 9 |
31086816 | USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability. | 2019 May |
1 |
| 10 |
31635307 | ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity. | 2019 Oct 18 |
2 |
| 11 |
29133939 | Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy. | 2018 Feb |
1 |
| 12 |
27016235 | Germline mutations of the DNA repair pathways in uterine serous carcinoma. | 2016 Apr |
1 |
| 13 |
27905519 | The impact of DNA damage response gene polymorphisms on therapeutic outcomes in late stage ovarian cancer. | 2016 Dec 1 |
1 |
| 14 |
25560806 | Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells. | 2015 Mar |
1 |
| 15 |
26210103 | Molecular landscape of prostate cancer: implications for current clinical trials. | 2015 Nov |
1 |
| 16 |
26674120 | ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers. | 2014 Dec |
1 |
| 17 |
12870966 | Nanoscale Pt(0) particles prepared in imidazolium room temperature ionic liquids: synthesis from an organometallic precursor, characterization, and catalytic properties in hydrogenation reactions. | 2003 Jul 28 |
1 |